Janssen Research articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/12/09 20:06
2014/12/09 20:06
9d
PHILADELPHIA — Researchers at Penn Medicine, in collaboration with a multi-center international team, have shown that a protease inhibitor, simeprevir, a once a day pill, along with interferon and...
2014/12/09 20:06
2014/12/09 20:06
Latest videos
2014/12/09 06:08
2014/12/09 06:08
10d
Results from the Phase 2 RESONATE™-17 (PCYC-1117) study show IMBRUVICA® (ibrutinib) was associated with an 82.6 percent investigator-assessed overall response rate (ORR; the primary endpoint) and a 79...
2014/11/26 05:08
2014/11/26 05:08
23d
Dossier for YONDELIS for advanced soft-tissue sarcoma received by the US FDA The results from a Phase III randomized, open label study are the basis for the submission of a registration dossier for...
2014/11/19 19:08
2014/11/19 19:08
29d
Janssen Research & Development, LLC (Janssen) today announced the submission of a New Drug Application (NDA) for three-month atypical antipsychotic paliperidone palmitate to the U.S. Food and Drug...
2014/11/18 16:17
2014/11/18 16:17
30d
CARLSBAD, Calif. & NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--The seventh annual Biotech Showcase™ investor conference will be held January 12–14, 2015 in San Francisco, CA at Parc 55 Wyndham San...
2014/11/15 22:41
2014/11/15 22:41
m
Among those in attendance at the Multiple Myeloma Research Foundation's recent Fall Gala in Greenwich were, from left, William N. Hait M.D., Ph.D., Global Head at Janssen Research and Development,...
2014/12/09 20:06
2014/12/09 20:06
Latest from Twitter